Tellgen Corp (300642) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Based on the latest financial reports, Tellgen Corp (300642) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.19 Million ≈ $5.30 Million USD) by net assets (CN¥1.53 Billion ≈ $223.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tellgen Corp - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Tellgen Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300642 liabilities breakdown for a breakdown of total debt and financial obligations.

Tellgen Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tellgen Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Guangdong Hongteo Accurate Technology Co Ltd
SHE:300176
0.066x
Holtek Semiconductor Inc
TW:6202
0.034x
PetroVietnam Transportation Corp
VN:PVT
0.081x
Autocanada Inc
TO:ACQ
-0.095x
PHX Energy Services Corporation
TO:PHX
0.090x
VT Industrial Technology Co Ltd
SHE:300707
0.049x
Vaibhav Global Limited
NSE:VAIBHAVGBL
0.047x
Jilin Jlu Communication Design Institute Co Ltd
SHE:300597
-0.010x

Annual Cash Flow Conversion Efficiency for Tellgen Corp (2012–2024)

The table below shows the annual cash flow conversion efficiency of Tellgen Corp from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 300642 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.52 Billion
≈ $222.14 Million
CN¥164.62 Million
≈ $24.09 Million
0.108x +31.75%
2023-12-31 CN¥1.54 Billion
≈ $224.72 Million
CN¥126.40 Million
≈ $18.50 Million
0.082x -26.01%
2022-12-31 CN¥1.48 Billion
≈ $216.67 Million
CN¥164.72 Million
≈ $24.10 Million
0.111x +88.02%
2021-12-31 CN¥1.40 Billion
≈ $204.32 Million
CN¥82.61 Million
≈ $12.09 Million
0.059x -22.61%
2020-12-31 CN¥1.27 Billion
≈ $185.34 Million
CN¥96.83 Million
≈ $14.17 Million
0.076x -48.90%
2019-12-31 CN¥1.17 Billion
≈ $171.01 Million
CN¥174.84 Million
≈ $25.59 Million
0.150x -5.02%
2018-12-31 CN¥1.02 Billion
≈ $149.87 Million
CN¥161.32 Million
≈ $23.61 Million
0.158x +33.13%
2017-12-31 CN¥895.86 Million
≈ $131.09 Million
CN¥106.00 Million
≈ $15.51 Million
0.118x -65.30%
2016-12-31 CN¥288.65 Million
≈ $42.24 Million
CN¥98.42 Million
≈ $14.40 Million
0.341x +1.41%
2015-12-31 CN¥192.33 Million
≈ $28.14 Million
CN¥64.67 Million
≈ $9.46 Million
0.336x +7.97%
2014-12-31 CN¥131.05 Million
≈ $19.18 Million
CN¥40.81 Million
≈ $5.97 Million
0.311x +12.41%
2013-12-31 CN¥95.04 Million
≈ $13.91 Million
CN¥26.33 Million
≈ $3.85 Million
0.277x +193.02%
2012-12-31 CN¥72.47 Million
≈ $10.60 Million
CN¥6.85 Million
≈ $1.00 Million
0.095x --

About Tellgen Corp

SHE:300642 China Medical Devices
Market Cap
$392.70 Million
CN¥2.68 Billion CNY
Market Cap Rank
#13773 Global
#4340 in China
Share Price
CN¥16.51
Change (1 day)
+0.30%
52-Week Range
CN¥13.71 - CN¥31.30
All Time High
CN¥46.24
About

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more